Screener
Kymera Therapeutics KYMR Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
FAQ
- What is Kymera Therapeutics's asset turnover?
- Kymera Therapeutics (KYMR) reported asset turnover of 0.1× in Q2 2026.
- How has Kymera Therapeutics's asset turnover changed year-over-year?
- Kymera Therapeutics's asset turnover increased by 65.4% year-over-year, from 0× to 0.1×.
- What is the long-term trend for Kymera Therapeutics's asset turnover?
- Over 5 years (2020 to 2025), Kymera Therapeutics's asset turnover has grown at a -23.9% compound annual growth rate (CAGR), from 0.1× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Kymera Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude